chr10-26217856-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001134366.2(GAD2):​c.151G>A​(p.Asp51Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000275 in 1,453,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

GAD2
NM_001134366.2 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.87

Publications

0 publications found
Variant links:
Genes affected
GAD2 (HGNC:4093): (glutamate decarboxylase 2) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22665656).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAD2NM_001134366.2 linkc.151G>A p.Asp51Asn missense_variant Exon 3 of 16 ENST00000376261.8 NP_001127838.1 Q05329Q5VZ30
GAD2NM_000818.3 linkc.151G>A p.Asp51Asn missense_variant Exon 3 of 17 NP_000809.1 Q05329Q5VZ30

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAD2ENST00000376261.8 linkc.151G>A p.Asp51Asn missense_variant Exon 3 of 16 1 NM_001134366.2 ENSP00000365437.3 Q05329
GAD2ENST00000259271.7 linkc.151G>A p.Asp51Asn missense_variant Exon 3 of 17 1 ENSP00000259271.3 Q05329
GAD2ENST00000428517.2 linkn.151G>A non_coding_transcript_exon_variant Exon 3 of 4 1 ENSP00000390434.2 Q5VZ31
GAD2ENST00000648567.1 linkc.-192G>A 5_prime_UTR_variant Exon 3 of 17 ENSP00000498009.1 A0A3B3IU09

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000131
AC:
3
AN:
228840
AF XY:
0.0000159
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000101
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000275
AC:
4
AN:
1453876
Hom.:
0
Cov.:
32
AF XY:
0.00000553
AC XY:
4
AN XY:
722686
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33262
American (AMR)
AF:
0.00
AC:
0
AN:
43776
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25784
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39570
South Asian (SAS)
AF:
0.0000350
AC:
3
AN:
85648
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51814
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5714
European-Non Finnish (NFE)
AF:
9.02e-7
AC:
1
AN:
1108352
Other (OTH)
AF:
0.00
AC:
0
AN:
59956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000168
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 28, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.151G>A (p.D51N) alteration is located in exon 3 (coding exon 3) of the GAD2 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the aspartic acid (D) at amino acid position 51 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
21
DANN
Benign
0.92
DEOGEN2
Benign
0.26
T;T
Eigen
Benign
0.095
Eigen_PC
Benign
0.20
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
.;D
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.23
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
7.9
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
0.25
N;N
REVEL
Benign
0.18
Sift
Benign
0.31
T;T
Sift4G
Benign
0.49
T;T
Polyphen
0.0
B;B
Vest4
0.37
MutPred
0.14
Gain of methylation at K54 (P = 0.0562);Gain of methylation at K54 (P = 0.0562);
MVP
0.68
MPC
0.41
ClinPred
0.31
T
GERP RS
5.9
Varity_R
0.11
gMVP
0.39
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762229020; hg19: chr10-26506785; API